Pathophysiology to Presentation: Translating Evidence to Improved Care of Patients with Fibromyalgia
neuroscienceCME Medical Simulation
Premiere Date: Monday, August 1, 2011This activity offers CE credit for:
- Physicians (CME)
- Nurses (CNE)
- Psychologists (APA)
- Social Workers (NASW)
- Certified Case Managers (CCMC)
- Pharmacists (ACPE)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Wednesday, August 1, 2012
Note: Credit Is No Longer Available
 | Lesley M. Arnold, MD Professor of Psychiatry and Behavioral Neuroscience Director, Women's Health Research Program University of Cincinnati College of Medicine Cincinnati, OH |
Fibromyalgia is a relatively common, wide-spread pain syndrome, estimated to affect 10% of women in a doctor's office at any given time. Fibromyalgia can present in a number of ways, "making each patient with [fibromyalgia] unique, complex, and potentially challenging to treat."
Educational efforts must start by improving not only recognition of the syndrome, but also clinician acceptance that it even exists as a disease entity. Although the situation seems to be improving, many clinicians remain skeptical that fibromyalgia is a legitimate condition, and this undoubtedly affects recognition and diagnosis. Survey data suggest that nearly 3 years and up to 4 physicians are required to provide an accurate diagnosis. Physicians need education regarding the growing evidence base regarding the neurobiological underpinnings of fibromyalgia and how these pathological findings translate into the clinical manifestations of the disease. Early recognition and prompt, appropriate treatment can improve health outcomes and quality of life for patients with fibromyalgia.
To improve physician performance in the diagnosis and management of patients with fibromyalgia by utilizing multiple decision points in a real-world patient case.
At the end of this CE activity, participants should be able to:
- Integrate knowledge of the neurobiology of fibromyalgia with the recognition and diagnosis of clinical symptoms.
- Utilize available assessment tools and diagnostic guidelines to provide prompt and accurate differential diagnosis of fibromyalgia.
- Weigh the evidence-based risks and benefits of available and emerging treatments to develop an individualized, multimodal treatment plan for patients with fibromyalgia.
Supported by an educational grant from Pfizer Inc.
Physicians, physician assistants, nurses, nurse practitioners, pharmacists, psychologists, social workers, certified case managers, and other health care professionals interested in the management of fibromyalgia.
CME Credit (Physicians):
Indiana University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Indiana University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.0 contact hour
CEP Credit (Psychologists):
CME Outfitters is approved by the American Psychological Association to sponsor continuing education for psychologists. CME Outfitters maintains responsibility for this program and its content. (1.0 CE credits)
NASW Credit (Social Workers):
This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.
CCMC Credit (Certified Case Managers):
This program has been approved for 1 hour by the Commission for Case Manager Certification (CCMC).
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Activity Number: 0376-9999-11-013-H01-P
Activity Type: application-based
Disclosure Declaration
It is the policy of Indiana University School of Medicine and CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. Indiana University School of Medicine and CME Outfitters, LLC, have evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Arnold has disclosed that she receives grants/research support from Boehringer Ingelheim Pharmaceuticals, Inc., Cypress Bioscience, Inc., Eli Lilly and Company, Forest Laboratories, Inc., and Novartis. She serves as a consultant to AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Cypress Bioscience, Inc., Eli Lilly and Company, Forest Laboratories, Inc., Pfizer Inc., sanofi-aventis, Takeda Pharmaceuticals North America, Inc., Grunenthal, Johnson & Johnson, and Wyeth Pharmaceuticals.
Tony Graham, MD (Content/peer reviewer) has no disclosures to report.
Ruth Cody, BSN, RN-BC (Content/peer reviewer) has no disclosures to report.
Nancy Jennings, MSN, MBA, MHA, RNC (Content/peer reviewer) has no disclosures to report.
Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.
Joy Bartnett Leffler, MLA, NASW, CSE (planning committee) has no disclosures to report.
Unlabeled Use Disclosure
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Indiana University School of Medicine, CME Outfitters, LLC, the faculty, and Pfizer Inc. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
PL-035-080111-02
